✦ LIBER ✦

The effect of peginterferon alfa-2a (40 KD) on liver histology in chronic hepatitis C: A meta-analysis of individual patients data

✍ Scribed by C. Camma; D. Di Bona; F. Schepis; E.J. Heathcote; S. Zeuzem; P.J. Pockros; P. Marcellin; A. Alberti; A. Craxi

Book ID: 117372418
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 165 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80510-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

23 The effect of peginterferon alfa-2a (

23 The effect of peginterferon alfa-2a (40KD) on liver histology in chronic hepatitis C: A meta-analysis of individual patients data (MIPD)

✍ Danilo Di Bona; Calogero Cammà; Filippo Schepis; E.Jenny Heathcote; Stefan Zeuze 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Effect of peginterferon alfa-2a on liver

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: A meta-analysis of individual patient data

✍ Calogero Cammà; Danilo Di Bona; Filippo Schepis; E. Jenny Heathcote; Stefan Zeuz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 1 views

Multicenter randomized trials have shown that once-weekly pegylated interferon (peginterferon) alfa-2a is more efficacious than conventional interferon alfa-2a (IFN) in patients with chronic hepatitis C. We performed a meta-analysis of 1,013 previously untreated patients (from 3 randomized trials) w

Pharmacokinetics of peginterferon ALFA-2

Pharmacokinetics of peginterferon ALFA-2A (40KD, PEGASYS) compared to peginterferon ALFA-2B (12KD, PEGINTRON) in naive patients with chronic hepatitis C (CHC)

✍ R. Bruno; P. Sacchi; V. Ciappina; E. Maffezzini; S.F.A. Patruno; C. Zocchetti; G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 319 KB

PIN9 A COST UTILITY ANALYSIS OF PEGINTER

PIN9 A COST UTILITY ANALYSIS OF PEGINTERFERON ALFA-2A (40 KD) VERSUS PEGINTERFERON ALFA-2B (I2KD) FOR THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN THE UK

✍ NR Latimer; GJ Lewis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

The safety, efficacy and pharmacokinetic

The safety, efficacy and pharmacokinetics of peginterferon Alfa-2a (40KD) in children with chronic hepatitis C

✍ Schwarz, Kathleen B.; Mohan, Parvathi; Narkewicz, Michael; Molleston, Jean P.; T 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Prediction of sustained virological resp

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin

✍ Foster, Graham R.; Fried, Michael W.; Hadziyannis, Stephanos J.; Messinger, Diet 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 392 KB